Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus VariantsFebruary 22, 2021
FDA Warns 10 Companies for Illegally Selling Dietary Supplements Claiming to Treat Depression and Other Mental Health DisordersFebruary 19, 2021
FDA Approves First in the World, First-of-Its-Kind Implant for the Treatment of Rare Bone Disease as a Humanitarian Use DeviceFebruary 17, 2021
FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based ProductsFebruary 8, 2021
FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell LymphomaFebruary 5, 2021
FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and OlderFebruary 5, 2021
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine CandidateFebruary 4, 2021
Coronavirus (COVID-19) Update: FDA Continues Important Work to Support Medical Product Development to Address New Virus VariantsFebruary 4, 2021
Coronavirus (COVID-19) Update: FDA Takes Action to Place All Alcohol-Based Hand Sanitizers from Mexico on Import Alert to Help Prevent Entry of Violative and Potentially Dangerous Products into U.S., Protect U.S. ConsumersJanuary 26, 2021
FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIVJanuary 21, 2021
